'We felt abandoned by our doctor...' When cancer patients enroll in hospice, they routinely face a sudden an abrupt change in their care team. While they may no longer require guidance from their oncologist, the loss of a known and trusted advisor can feel devastating. As pts…

The FDA's green light for our first-in-class IL-15 receptor marks a new era in treating #NMIBC . In this interview with Urology Times, Dr. Pat Soon-Shiong sheds light on the pivotal approval. #IBRX #BladderCancer
bit.ly/4b9qg3c

Today! Come by #AUA2024 Patient perspectives at 3:15 to be inspired by #kidneycancer patient Carie Gort and learn how she’s managing treatment related diarrhea through dietary changes.

Best part of conferences is time w friends who become family. Lovely 36h in San Antonio learning & sharing w Sarah P. Psutka MD MS Xiao Wei, MD Dena Battle Michael Staehler Lauren Meehan Machos, MPH
Not pictured: Petros Grivas Neeraj Agarwal, MD, FASCO #EvanYu KSridhar Brian Shuch, MD Eric A. Singer, MD, MA, MS, FACS, FASCO
Thanks #AUA24 !

#kidneycancer patient advocates at Fox Chase Cancer Center Department of Urology dinner. Many thanks to Alexander Kutikov MD for recognizing the value of pt voice at #AUA24 .

Two major health conditions, four different specialists, three health portals, and ONE major decision. Tracie Titus knocks it out of the park illustrating the navigational burden #kidneycancer pts face. #AUA2024

Thanks to Amer. Urol. Assn. and Pfizer Inc. for showcasing the #kidneycancer patient voice at #AUA2024 ! Tune in for Patient Perspectives today and tomorrow!

Thanks to the KCA team for their steadfast support, the entire scientific committee and all the speakers for their outstanding contribution. Thank you for making an amazing #IKCSEU24  
Kidney Cancer Vall d’Hebron Institute of Oncology (VHIO)

Yüksel Ürün Kidney Cancer Michael Staehler Salvatore La Rosa Laurence Albiges Cris Dena Battle Ignacio Duran Gretchen Vaughan OncoAlert KidneyCAN Uromigos UroToday.com Maite Bourlon Toni Choueiri, MD Emre Yekedüz Brian Rini, MD Tom Powles Sumanta K. Pal, MD, FASCO Nazli Dizman Neeraj Agarwal, MD, FASCO Rana McKay Viktor Grünwald James Brugarolas Great to see mRCC 1. L treatment has evolved and continues to do so. Kudos to all who make this progress happen. Yet how about 2. L and so for? And how about tRCC pts and other rare histologies?

Strong message: involve patient advocates in care and share knowledge openly, without paywalls.
Berit Eberhardt, Viktor Grünwald
Kidney Cancer Michael Staehler Salvatore La Rosa Laurence Albiges Cris Dena Battle Ignacio Duran #IKCSEU24 #Oncology #Cancer Gretchen Vaughan OncoAlert…

Profoundly candid assessment from giant in #kidneycancer Bernard Escudier. Investigators have responsibility in accepting being part of inadequate trials. #IKCSEU24

#trcc #kidneycancer pt Dawn Dyson gives a moving testimony of her experience with this rare subtype of RCC. Thank you for sharing your story at #IKCSEU24 , inspiring others, and articulating so clearly why more research is desperately needed.

Manuela Schmidinger never fails to impress. Thank you for being a fierce advocate for #kidneycancer patients. Congratulations and well deserved!

An outstanding and comprehensive overview of chromophobe RCC biology by Martin Voss #IKCSEU24 . Please see the recent review for more discussion on the biology of this tumor type in Cancer Cell cell.com/cancer-cell/ab…
Kidney Cancer

#IKCSEU24 starting now! I look forward to this meeting every year. Thanks to Gretchen Vaughan and Salvatore La Rosa for your advocacy and partnership. #StrongerTogether

About to start a great meeting!
Kidney Cancer Michael Staehler Salvatore La Rosa Laurence Albiges Cris Dena Battle Ignacio Duran #IKCSEU24 #Oncology #Cancer

Thank you to Cancer Discovery for offering us the opportunity to publish our work, simultaneous with #AACR24 ! Grateful to Elizabeth McKenna for facilitating a thoughtful but rapid peer review process to get this out in time for the meeting.
In #kidneycancer , we have been fortunate to have…